Context Therapeutics Inc.
CNTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001842952
No open-market purchases or sales by Context Therapeutics Inc. insiders were filed in the last 90 days; 79 institutions reported holding it in 13F filings for Q2 2026, worth $34.8M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Context Therapeutics Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −1 vs. Q4 2022
- Shares held
- 1.29M
- −2.42M (−65.2%) vs. Q4 2022
- Total value
- $722.6K
- −$1.70M (−70.2%) vs. Q4 2022
- New holders
- 4
- 3 more added
- Sold out
- 5
- 6 more reduced
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CNTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 79 | $34.8M |
| Q1 2026 | 60 | $194.6M |
| Q4 2025 | 43 | $96.0M |
| Q3 2025 | 37 | $66.8M |
| Q2 2025 | 39 | $45.0M |
| Q1 2025 | 42 | $43.7M |
| Q4 2024 | 52 | $76.4M |
| Q3 2024 | 42 | $111.2M |
| Q2 2024 | 34 | $114.3M |
| Q1 2024 | 25 | $5.43M |
| Q4 2023 | 24 | $4.02M |
| Q3 2023 | 23 | $3.89M |
| Q2 2023 | 22 | $3.58M |
| Q1 2023 | 22 | $722.6K |
| Q4 2022 | 24 | $2.55M |
| Q3 2022 | 24 | $4.59M |
| Q2 2022 | 20 | $6.32M |
| Q1 2022 | 16 | $6.30M |
| Q4 2021 | 19 | $9.44M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Context Therapeutics Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 573,400 | $322.4K | 0.00% | −67,463−10.5% | Reduced |
| HighTower Advisors, LLC | 125,852 | $71.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 105,809 | $59.5K | 0.00% | 00.0% | Unchanged |
| Mill Creek Capital Advisors, LLC | 104,631 | $58.8K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 59,568 | $33.5K | 0.00% | −1,634−2.7% | Reduced |
| Two Sigma Investments, LP | 55,688 | $31.3K | 0.00% | +29,154+109.9% | Added |
| Virtu Financial LLC | 41,191 | $23.0K | 0.00% | −16,264−28.3% | Reduced |
| Northern Trust Corp | 37,219 | $20.9K | 0.00% | 00.0% | Unchanged |
| Difesa Capital Management, LP | 34,878 | $19.6K | 0.02% | 00.0% | Unchanged |
| State Street Corp | 32,907 | $18.5K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 24,599 | $13.8K | 0.00% | +24,599 | New |
| Sheets Smith Wealth Management | 20,000 | $11.2K | 0.00% | +20,000 | New |
| Renaissance Technologies LLC | 19,200 | $11.0K | 0.00% | −86,100−81.8% | Reduced |
| Two Sigma Advisers, LP | 16,200 | $9.11K | 0.00% | +16,200 | New |
| Aspire Wealth Management Corp | 10,000 | $5.62K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 8,843 | $5.00K | 0.00% | −14−0.2% | Reduced |
| Baader Bank INC | 10,651 | $4.67K | 0.00% | +10,651 | New |
| UBS Group AG | 5,767 | $3.24K | 0.00% | +3,012+109.3% | Added |
| Federation des caisses Desjardins du Quebec | 400 | $225 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 103 | $58 | 0.00% | +2+2.0% | Added |
| Bank of America Corp | 100 | $56 | 0.00% | −17−14.5% | Reduced |
| Retirement Group, LLC | 155 | $0 | 0.00% | 00.0% | Unchanged |
| AIGH Capital Management LLC | 0 | $0 | 0.00% | −1,143,745−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −883,654−100.0% | Sold out |
| Worth Venture Partners, LLC | 0 | $0 | 0.00% | −281,889−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −19,827−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −19,350−100.0% | Sold out |
| swisspartners Ltd. | – | – | – | – | Not filed |